multiple myeloma treatment research

Latest Post

FDA Hosts Webinar on ICH M15 Guidance for Model-Informed Drug Development Baby Memorial Hospital Group Partners With DeepInfinity.AI to Scale Clinical AI Molecular Partners Plans 44% Workforce Reduction to Focus on Radiotherapeutics Geron Discontinues Phase III Myelofibrosis Trial After Survival Goal Setback Biogen Q3 2026 Results: Revenue Rises 11% as Company Raises Earnings Guidance

India CAR-T Therapy Development: Nucelion, VeGen Bio Pact

October 23, 2026 Simone Lamb

India CAR-T therapy development gets a boost as Nucelion and VeGen Bio partner on VL-2511, an experimental dual-target myeloma therapy.

You missed

FDA Hosts Webinar on ICH M15 Guidance for Model-Informed Drug Development

October 30, 2026 Simone Lamb

Baby Memorial Hospital Group Partners With DeepInfinity.AI to Scale Clinical AI

October 30, 2026 Simone Lamb

Molecular Partners Plans 44% Workforce Reduction to Focus on Radiotherapeutics

October 30, 2026 Simone Lamb

Geron Discontinues Phase III Myelofibrosis Trial After Survival Goal Setback

October 30, 2026 Simone Lamb